Tandem Diabetes Care Welcomes Bruce W. Bode, MD, FACE, to Clinical Advisory Board
SAN DIEGO, CA, August 04, 2010
Tandem Diabetes Care, Inc., a privately-held company, today announced Bruce W. Bode, M.D., FACE, a known advocate for insulin pump therapy, has joined its clinical advisory board.
Dr. Bode is a diabetes specialist with the Atlanta Diabetes Associates in Georgia, and is a clinical associate professor at Emory University in the Department of Medicine. He has served on the board of directors of the Atlanta chapters of the Juvenile Diabetes Research Foundation (JDRF), the American Diabetes Association (ADA), and various Georgia-based diabetes camps. Dr. Bode is an active member of the JDRF research team validating the efficacy and safety of real-time continuous glucose monitoring (CGM), and is a former president of the ADA Georgia Affiliate and editor of the ADA’s 2004 edition of, Medical Management of Type 1 Diabetes.
“Our Clinical Advisory Board continues to expand with distinguished healthcare professionals such as Dr. Bode. The total years of experience with diabetes and insulin infusion therapy on our board bring immeasurable contribution to our product innovation,” said Kim Blickenstaff, President and Chief Executive Officer of Tandem Diabetes Care, Inc.
Dr. Bodereceived his medical degree from Emory University School of Medicine in Atlanta, Ga., and completed a fellowship in diabetes with Paul C. Davidson, MD, and an internship and residency at Emory University Affiliated Hospitals.
About Tandem Diabetes Care, Inc.
Dedicated to advancing the management of diabetes, Tandem Diabetes Care, Inc. is an innovative company that uses novel technology in the development medical devices for insulin administration. Founded in 2006, Tandem is based in San Diego, California.